| Heading: |
Prostate Cancer: Genetics |
| Question ID: |
1825194 |
| UIN: |
HL9718 |
| House: |
Lords |
| Date tabled: |
2025-07-21 |
| Asking Member ID: |
1796 |
| Asking Member display name: |
Lord Taylor of Warwick
|
| Asking Member handle: |
Lord_ofWarwick
|
| Asking Member Twitter reference: |
@Lord_ofWarwick
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what assessment they have made of current eligibility guidelines of BRCA1 gene testing, and how testing allows early detection of heightened risk of prostate cancer. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-08-04 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Genomic testing in the National Health Service in England is delivered in line with the National Genomic Test Directory. The test directory outlines eligibility criteria and testing methods for over 200 cancer indications, including BRCA1 and BRCA2 testin... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |